Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Halozyme Therapeutics›
Website
AddedFeb 19, 2024
UpdatedJun 18, 2026
Halozyme Therapeutics

Halozyme Therapeutics

Public

Halozyme Therapeutics, Inc.: A biotech firm innovating in diabetes, cancer, dermatology, and drug delivery.

HQ
San Diego, CA, US
Founded
1998
Loading
Overview
Compare
Fundraising
Employees
Website

Halozyme Therapeutics - Website

An index of every page on halozyme.com, by section.

31 pages across 7 sections · Updated Jul 11, 2026·

Homepage

Halozyme Therapeutics's front door: current positioning and top-line messaging.

halozyme.com

Careers

Open roles and how Halozyme Therapeutics recruits: 6 careers pages straight from the source.

halozyme.com/careers
  • Halozyme Benefit Highlights 2025
  • Halozyme56240
  • Halo Careers Header
  • Careers Header
  • Wellbeing/careers/attachment/wellbeing

BlogNews

Product updates, deep-dives, and company thinking: Halozyme Therapeutics's 6-post archive.

halozyme.com/news
  • Halo News Pr/news/attachment/halo_news_pr
  • Halo News Header
  • Insights/news/attachment/insights
  • Press Releases/news/attachment/press_releases
  • News Header/news/attachment/news_header

PrivacyPrivacy Policy

How Halozyme Therapeutics collects, uses, and safeguards data: the canonical policy set.

halozyme.com/privacy-policy

AboutAbout Us

Company story, mission, and background as Halozyme Therapeutics tells it.

halozyme.com/about-us
  • About Focus 1
  • By the Numbers
  • Values Lightbulb
  • Values Atom/about-us/attachment/values_atom
  • Values Scale

TeamDarren Snellgrove

Leadership and the people behind Halozyme Therapeutics, as the company presents them.

  • Darren Snellgrove/leadership/darren-snellgrove
  • Jeffrey W Henderson 2
  • Charles Theuer Md Phd
  • Jim Lang/leadership/jim-lang
  • Mark Snyder/leadership/mark-snyder
  • Chris Wahl/leadership/chris-wahl

Contact

Sales, support, and partnership channels for reaching Halozyme Therapeutics directly.

halozyme.com/contact
  • Map Contact/contact/attachment/map_contact
  • Contact Map/contact/attachment/contact_map
  • Contact Footer Bg
  • Contact Header